Day CP - Search Results

1

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. McPherson S, et al. Among authors: day cp. Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077. Gut. 2010. PMID: 20801772

2

Genetic predisposition to alcoholic liver disease.

Day CP, Bassendine MF. Day CP, et al. Gut. 1992 Nov;33(11):1444-7. doi: 10.1136/gut.33.11.1444. Gut. 1992. PMID: 1452064 Free PMC article. Review. No abstract available.

3

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

Teli MR, Day CP, Burt AD, Bennett MK, James OF. Teli MR, et al. Among authors: day cp. Lancet. 1995 Oct 14;346(8981):987-90. doi: 10.1016/s0140-6736(95)91685-7. Lancet. 1995. PMID: 7475591

4

The natural history of nonalcoholic fatty liver: a follow-up study.

Teli MR, James OF, Burt AD, Bennett MK, Day CP. Teli MR, et al. Among authors: day cp. Hepatology. 1995 Dec;22(6):1714-9. Hepatology. 1995. PMID: 7489979

5

Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.

Brown AS, Fiaterone JR, Day CP, Bennett MK, Kelly PJ, James OF. Brown AS, et al. Among authors: day cp. Gut. 1995 Sep;37(3):413-7. doi: 10.1136/gut.37.3.413. Gut. 1995. PMID: 7590440 Free PMC article. Clinical Trial.

6

Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesis.

Day CP, Burt AD, Brown AS, Bennett MK, Farrell DJ, James OF, Yeaman SJ. Day CP, et al. Clin Sci (Lond). 1993 Sep;85(3):281-7. doi: 10.1042/cs0850281. Clin Sci (Lond). 1993. PMID: 8403799

7

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. Among authors: day cp. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

8

Alcoholic liver disease: dose and threshold--new thoughts on an old topic.

Day CP. Day CP. Gut. 1997 Dec;41(6):857-8. doi: 10.1136/gut.41.6.857. Gut. 1997. PMID: 9462225 Free PMC article. No abstract available.

9

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Smith BC, et al. Among authors: day cp. Hepatology. 1998 Jun;27(6):1695-9. doi: 10.1002/hep.510270631. Hepatology. 1998. PMID: 9620344

10

Diagnosis and interpretation of steatosis and steatohepatitis.

Burt AD, Mutton A, Day CP. Burt AD, et al. Among authors: day cp. Semin Diagn Pathol. 1998 Nov;15(4):246-58. Semin Diagn Pathol. 1998. PMID: 9845426 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters